PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Surgery

NEXT STORY
Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD
PREV STORY
Roche reports very strong sales growth in the first nine months of 2019 – outlook raised
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Oligonucleotide Synthesis Market to 2023

Dublin, Aug. 30, 2018 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market by Offering, by ...

author_avatar
NASDAQ Market News

Calithera Biosciences to Report Fourth Quarter and Year-End 2016 Financial Results on Thursday, March 16, 2017

SOUTH SAN FRANCISCO, Calif., March 10, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News

Loxo Oncology to Present at Upcoming Investor Conferences

STAMFORD, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News